Market Overview:
The global plasma therapeutics market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of chronic diseases, rising demand for plasma-derived products, and technological advancements in the field of plasma therapeutics. The human serum protein segment is expected to dominate the global market during the forecast period owing to its wide range of applications in research laboratories and institutions, hospitals, and stand-alone blood banks. The immunoglobulins segment is projected to grow at a high CAGR during the forecast period owing to its increasing demand for prophylactic and therapeutic uses. Geographically, North America dominates the global market for plasma therapeutics due to factors such as early adoption of new technologies, well-developed healthcare infrastructure, and presence of major players in this region.
Product Definition:
Plasma therapeutics are treatments that use the properties of plasma to help improve health. Plasma is a component of blood that contains important proteins and clotting factors. It can be used to treat a variety of medical conditions, including bleeding disorders, burns, and shock.
Human Serum Protein:
Human serum protein is a nutritional supplement derived from the blood of healthy donors. It contains all the essential amino acids and has been used as an alternative source for dietary proteins. The product also acts as a source of various growth factors such as transforming growth factor, platelet-derived growth factor, insulin-like Growth Factor I (IGF-1), vascular endothelial cell growth factor and interleukin (IL) - 1 & 2 among others.
Plasma-Derived Clotting Factor:
Plasma-derived clotting factor is a protein that facilitates the normal coagulation process. It is also known as Protein C. The factor was first identified in plasma and has been commercialized as an injectable drug for treatment of hemophilia A and B patients. Plasma-derived clotting factor (PFCF) acts by binding to Factor IXa, which results in activation of the intrinsic coagulation pathway leading to thrombus formation.
Application Insights:
On the basis of application, the global market has been segmented into research laboratories and institutions, hospitals, and stand-alone blood banks. Research laboratories held the largest share in 2017 owing to increasing government funding for stem cell research. Institutes such as Indian Institute of Science are supported by Ministry of Science & Technology; Department of Biotechnology to carry out advanced R&D activities related to stem cells in India.
Stand-alone blood banks are anticipated to register fastest growth over forecast period due to rising need for transfusion therapy across various regions coupled with growing awareness about banking standards among population at large. Increasing number of fatal accidents caused by improper handling or storage of blood is also expected fuel demand over next few years.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high R&D investment by them and their efforts to commercialize plasma-derived therapeutics at a relatively low price. The region is expected to maintain its dominance throughout the forecast period owing to factors such as favorable reimbursement policies, increasing geriatric population prone to chronic diseases, and rising healthcare expenditure levels.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing with rapid economic development coupled with improving healthcare infrastructure in emerging countries such as China and India will drive this regional market.
Growth Factors:
- Increasing incidence of chronic diseases: The prevalence of chronic diseases is increasing at an alarming rate across the globe. This is primarily attributed to the changing lifestyle and dietary habits of people. Plasma therapeutics helps in the treatment of various chronic diseases such as cancer, autoimmune disorders, and genetic disorders. Thus, the demand for plasma therapeutics is expected to rise in the coming years.
- Technological advancements: The field of plasma therapeutics is witnessing rapid technological advancements owing to which new and innovative therapies are being developed on a regular basis. This is likely to boost the growth prospects of this market in the near future.
- Rising awareness about plasma-based therapies: There has been a significant increase in awareness about plasma-based therapies among healthcare professionals as well as patients in recent years due to their efficacy and safety profile compared with other treatment options available currently.. This is likely to propel demand for these therapies in the coming years..
Scope Of The Report
Report Attributes
Report Details
Report Title
Plasma Therapeutics Market Research Report
By Type
Human Serum Protein, Plasma-Derived Clotting Factor, Immunoglobulins, High Immunoglobulins
By Application
Research Laboratories And Institutions, Hospitals, Stand-Alone Blood Banks
By Companies
Baxter, CSL Behring, Grifols Therapeutics, Octapharma, Abeona Therapeutics, ADMA Biologics, Amag Pharmaceuticals, Antares Pharma, BioDelivery Sciences, Bio Products Laboratory, Biota Pharmaceuticals, Biotest Pharmaceuticals, China Biologic Products
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
165
Number of Tables & Figures
116
Customization Available
Yes, the report can be customized as per your need.
Global Plasma Therapeutics Market Report Segments:
The global Plasma Therapeutics market is segmented on the basis of:
Types
Human Serum Protein, Plasma-Derived Clotting Factor, Immunoglobulins, High Immunoglobulins
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research Laboratories And Institutions, Hospitals, Stand-Alone Blood Banks
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Baxter
- CSL Behring
- Grifols Therapeutics
- Octapharma
- Abeona Therapeutics
- ADMA Biologics
- Amag Pharmaceuticals
- Antares Pharma
- BioDelivery Sciences
- Bio Products Laboratory
- Biota Pharmaceuticals
- Biotest Pharmaceuticals
- China Biologic Products
Highlights of The Plasma Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Human Serum Protein
- Plasma-Derived Clotting Factor
- Immunoglobulins
- High Immunoglobulins
- By Application:
- Research Laboratories And Institutions
- Hospitals
- Stand-Alone Blood Banks
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Plasma Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Plasma therapeutics is a new field of medicine that uses plasma proteins to treat diseases. Plasma proteins are the building blocks of blood, and when they are used in treatments, they can help to improve the body's ability to fight disease. Plasma therapeutics is still in its early stages, and there is still much research that needs to be done before it can be used as a mainstream treatment option. However, plasma therapies have shown great potential for treating a variety of diseases.
Some of the key players operating in the plasma therapeutics market are Baxter, CSL Behring, Grifols Therapeutics, Octapharma, Abeona Therapeutics, ADMA Biologics, Amag Pharmaceuticals, Antares Pharma, BioDelivery Sciences, Bio Products Laboratory, Biota Pharmaceuticals, Biotest Pharmaceuticals, China Biologic Products.
The plasma therapeutics market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Plasma Therapeutics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Plasma Therapeutics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Plasma Therapeutics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Plasma Therapeutics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Plasma Therapeutics Market Size & Forecast, 2018-2028
4.5.1 Plasma Therapeutics Market Size and Y-o-Y Growth
4.5.2 Plasma Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Plasma Therapeutics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Plasma Therapeutics Market Size Forecast by Type
5.2.1 Human Serum Protein
5.2.2 Plasma-Derived Clotting Factor
5.2.3 Immunoglobulins
5.2.4 High Immunoglobulins
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Plasma Therapeutics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Plasma Therapeutics Market Size Forecast by Applications
6.2.1 Research Laboratories And Institutions
6.2.2 Hospitals
6.2.3 Stand-Alone Blood Banks
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Plasma Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Plasma Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Plasma Therapeutics Analysis and Forecast
9.1 Introduction
9.2 North America Plasma Therapeutics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Plasma Therapeutics Market Size Forecast by Type
9.6.1 Human Serum Protein
9.6.2 Plasma-Derived Clotting Factor
9.6.3 Immunoglobulins
9.6.4 High Immunoglobulins
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Plasma Therapeutics Market Size Forecast by Applications
9.10.1 Research Laboratories And Institutions
9.10.2 Hospitals
9.10.3 Stand-Alone Blood Banks
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Plasma Therapeutics Analysis and Forecast
10.1 Introduction
10.2 Europe Plasma Therapeutics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Plasma Therapeutics Market Size Forecast by Type
10.6.1 Human Serum Protein
10.6.2 Plasma-Derived Clotting Factor
10.6.3 Immunoglobulins
10.6.4 High Immunoglobulins
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Plasma Therapeutics Market Size Forecast by Applications
10.10.1 Research Laboratories And Institutions
10.10.2 Hospitals
10.10.3 Stand-Alone Blood Banks
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Plasma Therapeutics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Plasma Therapeutics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Plasma Therapeutics Market Size Forecast by Type
11.6.1 Human Serum Protein
11.6.2 Plasma-Derived Clotting Factor
11.6.3 Immunoglobulins
11.6.4 High Immunoglobulins
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Plasma Therapeutics Market Size Forecast by Applications
11.10.1 Research Laboratories And Institutions
11.10.2 Hospitals
11.10.3 Stand-Alone Blood Banks
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Plasma Therapeutics Analysis and Forecast
12.1 Introduction
12.2 Latin America Plasma Therapeutics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Plasma Therapeutics Market Size Forecast by Type
12.6.1 Human Serum Protein
12.6.2 Plasma-Derived Clotting Factor
12.6.3 Immunoglobulins
12.6.4 High Immunoglobulins
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Plasma Therapeutics Market Size Forecast by Applications
12.10.1 Research Laboratories And Institutions
12.10.2 Hospitals
12.10.3 Stand-Alone Blood Banks
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Plasma Therapeutics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Plasma Therapeutics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Plasma Therapeutics Market Size Forecast by Type
13.6.1 Human Serum Protein
13.6.2 Plasma-Derived Clotting Factor
13.6.3 Immunoglobulins
13.6.4 High Immunoglobulins
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Plasma Therapeutics Market Size Forecast by Applications
13.10.1 Research Laboratories And Institutions
13.10.2 Hospitals
13.10.3 Stand-Alone Blood Banks
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Plasma Therapeutics Market: Competitive Dashboard
14.2 Global Plasma Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Baxter
14.3.2 CSL Behring
14.3.3 Grifols Therapeutics
14.3.4 Octapharma
14.3.5 Abeona Therapeutics
14.3.6 ADMA Biologics
14.3.7 Amag Pharmaceuticals
14.3.8 Antares Pharma
14.3.9 BioDelivery Sciences
14.3.10 Bio Products Laboratory
14.3.11 Biota Pharmaceuticals
14.3.12 Biotest Pharmaceuticals
14.3.13 China Biologic Products
